medigraphic.com

2006, Número 4

<< Anterior Siguiente >>

Cir Cir 2006; 74 (4)


Hidradenitis supurativa

Charúa-Guindic L, Maldonado-Barrón R, Avendaño-Espinosa O, Navarrete-Cruces T, Osorio-Hernández RM, Jiménez-Bobadilla B

Idioma: Español
Referencias bibliográficas: 46
Paginas: 249-255
Archivo PDF: 170.97 Kb.


RESUMEN

Introducción: la hidradenitis supurativa es una enfermedad inflamatoria, crónica, recurrente, originada en las glándulas apocrinas; se puede localizar en axila, ingle, periné, región anoperineal y cuero cabelludo.
Objetivo: conocer la frecuencia y el manejo terapéutico.
Material y métodos: se trató de un estudio retrospectivo, transversal y descriptivo, Se incluyeron los pacientes portadores de hidradenitis supurativa atendidos en la Unidad de Coloproctología del Servicio de Gastroenterología, Hospital General de México, de enero de 1995 a diciembre de 2004.
Resultados: se revisaron 12,689 expedientes clínicos y se identificaron 15 pacientes (0.12 %), de los cuales nueve cumplieron los criterios de inclusión.
Conclusiones: la hidradenitis supurativa es una enfermedad compleja que constituye un reto diagnóstico y terapéutico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. 1. Mitchell KM, Beck DE. Hidradenitis suppurativa. Surg Clin North Am 2002;6:1147-1156.

  2. 2. Bocchini SF, Habr-Gama A, Kiss DR, Imperiale AR, Araujo SE. Gluteal and perianal hidradenitis suppurativa, surgical treatment by wide excision. Dis Colon Rectum 2003;46:944-949.

  3. 3. Von Der Werth JM, Willians HC, Raeburn JA. The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol 2000;142:947-953.

  4. 4. Velpeau A. Aisselle. In: Dictionnaire de médicine, un répertoire général des sciences médicales sous le rapport théorique et pratique. Paris: Bechet jeune; 1839.p.2.

  5. 5. Vernuil A. De I’hidrosadénite phlegmoneuse et des abscés sudoripares. Arch Gen Med Paris 1864;114:537-557.

  6. 6. Schiefferdecker P. Uber morphologische Sekretionserscheinungen in den ekkrinen Hautdrusen des Mensschen. Arch Dermatol Syph 1921;132:130.

  7. 7. Woollard HH. The cutaneous glands of man. J Anat 1930;64:415.

  8. 8. Brunsting HA. Hidradenitis suppurativa; abscess of the apocrine sweat glands. Arch Dermatol Syph 1939;39:108.

  9. 9. Benerjee AK. Surgical treatment of hidradenitis suppurativa. Br J Surg 1992;79:863-866.

  10. 10. Carmen C, Yu W, Cook MG. Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands. Br J Dermatol 1990;122:763-769.

  11. 11. Domonkos AN, Arnold HL, Odom RB, Andrews. Tratado de dermatología. 3ª. ed. España: Salvat; 1987. pp. 1-4

  12. 12. Wiltz O, Shoetz Jr. DJ, Murray JJ, Roberts PL, Coller JA, Veidenheimer MC. Perianal hidradenitis suppurativa: the Lahey Clinic experience. Dis Colon Rectum 1990:33:731-734.

  13. 13. Corman ML. Colon and Rectal Surgery, 4th ed. Philadelphia: Lippicott-Raven;1998. pp. 224-171.

  14. 14. Goligher J. Cirugía del ano, recto y colon. 2ª Ed. Masson; 1987. pp. 205-209.

  15. 15. Bendahan J, Paran H, Colman S, Neufeld DM, Freund U. The possible role of Chlamydia trachomatis in perineal suppurative hidradenitis. Eur J Surg 1992;158:213-215.

  16. 16. Culp CE. Chronic hidradenitis suppurativa of the anal canal. A surgical skin disease. Dis Colon Rectum 1983;26:669-676.

  17. 17. Goldberg S. Fundamentos de cirugía anorrectal. 1a. ed. Limusa Noriega;1990. pp. 429-430.

  18. 18. Highet AS, Warren RE, Weekes AJ. Bacteriology and antibiotic treatment of perineal suppurative hidradenitis. Arch Dermatol 1988;124:1047-1051.

  19. 19. Gilliland R, Wexner SD. Complicated anorectal sepsis. Surg Clin North Am 1997;77:115-153.

  20. 20. Barth JH, Kealey T. Androgen metabolism by isolated human axillary apocrine glands in hidradenitis suppurativa. Br J Dermatol 1991;

  21. 125:304-308.

  22. 21. Barth JH, Laytan AM, Cunliffe WJ. Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol 1996;134:1057-1059.

  23. 22. Mortimer PS, Dawber RPR, Gales MA, Moore RA. Mediation of hidradenitis suppurativa by androgens. Br Med J (Clin Res Ed) 1986;292:245-248.

  24. 23. Harrison BJ, Read GF, Hughess LE. Endocrine basis for the clinical presentation of hidradenitis suppurativa. Br J Surg 1988:75:972-975.

  25. 24. Fitzsimmons JS, Fitzsimmons EM, Gilbert G. Familial hidradenitis suppurativa: evidence in favor of single gene transmissions. J Med Genet 1984;21:281-285.

  26. 25. Jemec GBE. The symptomatology of hidradenitis suppurativa in women. Br J Dermatol 1988;119:345-350.

  27. 26. Montgomery JR, White TW, Turner ML. A novel connexin 26 gene mutation associated with features of the keratitis-ichthyosis-deafness syndrome and the follicular occlusion triad. J Am Dermatol 2004;51:377-382.

  28. 27. Kurzen H, Jung EG, Hartschuh W, Moll I, Franke WW, Moll R. Forms of epithelia differentiation of draining sinus in acne inversa (hidradenitis suppurativa). Br J Dermatol 1999;141:231-239.

  29. 28. Roy MK, Appleton AC, Delicata RJ, Sharma AK, Williams GT, Carey PD. Probable association between hidradenitis suppurativa and Crohn’s disease: significance of epitheloid granuloma. Br J Surg 1997;84:375-375.

  30. 29. Ostlere LS, Langtry JA, Mortimer PS, Staughton RCD. Hidradenitis suppurativa in Crohn’s disease. Br J Dermatol 1991;125:384-386.

  31. 30. Gower-Rousseau C, Maunoury V, Colombel JF, et al. Hidradenitis suppurativa and Crohn’s disease in two families: a significant association. Am J Gastroenterol 1992;87:928.

  32. 31. Burrows NP, Russel JR. Crohn’s disease in association with hidradenitis suppurativa. Br J Dermatol 1992;122:523.

  33. 32. Jemec G, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol;1998;39:971-974.

  34. 33. Gupta AK, Ellis CN, Nickoloff BJ, et al. Oral cyclosporine in the treatment of inflammatory and noninflamatory dermatoses. Arch Dermatol 1990;126:339-350.

  35. 34. Leb Wohl B, Spadin AN. Infliximab for the treatment of hidradenitis suppurativa. J Am Acad Dermatol 2003;49:670-672.

  36. 35. Katansas KH, Christodoulou DK. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn’s disease patient. Am J Gastroenterol 2002;97:2155-2156.

  37. 36. Sullivan TP, Kerdel FA, Welsh E, Burdick AE, Kirsner RS. Infliximab for hidradenitis suppurativa. Br J Dermatol 2003;149:1046-1049.

  38. 37. Mortimer PS, Dawber RP, Gales MA, et al. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 1986;115:263-268.

  39. 38. Brown CF, Gallup DG, Brown VM. Hidradenitis suppurativa of the anogenital region: response to isotretinoin. Am J Obstet Gynecol 1988;158:12-15.

  40. 39. Lapins J, Startorius K. Emtestam L. Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa. J Am Acad Dermatol 2002;47:280-285.

  41. 40. Brown SC, Kazzazi N, Lord PH. Surgical treatment of perineal hidradenitis suppurativa with special reference to recognition of the perineal form. Br J Surg 1986;73:978-980.

  42. 41. Watson JD. Hidradenitis suppurativa—a clinical review. Br J Plast Surg 1985;38:567-569.

  43. 42. Parks RW, Parks TG. Pathogenesis, clinical features and management of hidradenitis suppurativa. Ann R Coll Surg Engl 1997;79:83-89.

  44. 43. Rompel R, Petres J. Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol Surg 2000;

  45. 26:638-643.

  46. 44. Lapins J, Ye W, Nyrèn O, Emtestam L. Incidence of cancer among pa-tients with hidradenitis suppurativa. Arch Dermatol 2001;137:730-734.




2020     |     www.medigraphic.com